A detailed history of Fsa Wealth Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Fsa Wealth Management LLC holds 384 shares of BIIB stock, worth $60,633. This represents 0.03% of its overall portfolio holdings.

Number of Shares
384
Previous 344 11.63%
Holding current value
$60,633
Previous $74,000 -0.0%
% of portfolio
0.03%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$189.07 - $236.8 $7,562 - $9,472
40 Added 11.63%
384 $74,000
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $76,570 - $92,171
344 New
344 $89,000
Q1 2021

May 17, 2021

SELL
$242.95 - $284.63 $85,032 - $99,620
-350 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$236.26 - $355.63 $82,691 - $124,470
350 New
350 $86,000
Q3 2020

Nov 13, 2020

SELL
$264.77 - $305.71 $92,669 - $106,998
-350 Closed
0 $0
Q4 2019

Feb 21, 2020

BUY
$220.06 - $304.07 $77,021 - $106,424
350 New
350 $104,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Fsa Wealth Management LLC Portfolio

Follow Fsa Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fsa Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fsa Wealth Management LLC with notifications on news.